Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

New p73 variants with altered C-terminal structures have varied transcriptional activities

Abstract

p73 has been identified as a protein which shares significant homology with the tumor suppressor p53. We found two new types of splicing variant mRNAs for p73 expressed in MCF-7 cells which we named p73γ and ε. Sequence analysis revealed that these mRNAs encode variant p73 proteins bearing distinct carboxy-terminal structures, which are also different from the previously reported variants p73α and β. The mRNAs encoding p73γ and ε as well as α and β were confirmed to be expressed in normal human tissues in varied patterns. All of these splicing variants activated promoter with the p53-binding consensus sequence, but to different degrees. Furthermore, suppressive effects of p73α, γ and ε, but not β, on endogenous p53 activity were observed when transiently expressed in HepG2 and MCF-7 cells. These results suggested that the carboxy-terminal regions of p73 which were altered by alternative splicing affect these transactivation abilities and modulate the functions of p73 molecules.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  • Bartek J, Iggo R, Gannon J and Lane DP. . 1990 Oncogene 5: 893–899.

  • Cheng J and Haas M. . 1990 Mol. Cell Biol. 10: 5502–5509.

  • Diller L, Kassel J, Nelson CE, Gryka MA, Litwak G, Gebhardt M, Bressac B, Ozturk M, Baker SJ, Vogelstein B and Friend SH. . 1990 Mol. Cell Biol. 10: 5772–5781.

  • El-Diery WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW and Vogelstein B. . 1994 Cancer Res. 54: 1169–1174.

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. . 1993 Cell 75: 817–825.

  • Hassapoglidou S, Diamandis EP and Sutherland DJ. . 1993 Oncogene 8: 1501–1509.

  • Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K and Shimotohno K. . 1993 J. Virol. 67: 4665–4675.

  • Jost CA, Marin MC and Kaelin Jr WG. . 1997 Nature 389: 191–194.

  • Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. . 1997 Cell 90: 809–819.

  • Kiyono T, Hiraiwa A, Ishii S, Takahashi T and Ishibashi M. . 1994 J. Virol. 68: 4656–4661.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Levine AJ. . 1997 Cell 88: 323–331.

  • Lopez AJ. . 1995 Dev. Biol. 172: 396–411.

  • Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J and Ozturk M. . 1993 FASEB J. 7: 1407–1413.

  • Siebert PD and Larrick JW. . 1992 Nature 359: 557–558.

  • Tominaga O, Hamelin R, Trouvat V, Salmon RJ, Lesec G, Thomas G and Remvikos Y. . 1993 Oncogene 8: 2653–2658.

Download references

Acknowledgements

We thank Dr Tohru Kiyono for providing the plasmids pCAST2Bluc and p-55Bluc. This work was supported by grants-in-aid for cancer research and for the second-term comprehensive 10-year strategy for cancer control from the Ministry of Health and Welfare and by grants-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ueda, Y., Hijikata, M., Takagi, S. et al. New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene 18, 4993–4998 (1999). https://doi.org/10.1038/sj.onc.1202817

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202817

Keywords

This article is cited by

Search

Quick links